Jérôme Bédier
Amministratore Delegato presso Flash Therapeutics SAS
Profilo
Jérôme Bédier is currently the President & Chief Executive Officer at Flash Therapeutics SAS since 2023.
Prior to this, he worked as the Chief Operating Officer at Cell-Easy SAS.
Posizioni attive di Jérôme Bédier
Società | Posizione | Inizio |
---|---|---|
Flash Therapeutics SAS
Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Amministratore Delegato | 06/07/2023 |
Precedenti posizioni note di Jérôme Bédier
Società | Posizione | Fine |
---|---|---|
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Flash Therapeutics SAS
Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Commercial Services |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Commercial Services |
- Borsa valori
- Insiders
- Jérôme Bédier